Ken Takanashi, Director at Wave Life Sciences, Inc. (WVE), sold 3,864 shares at $6.01 ($23K) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STSA | BUY | 2019-09-17 | $3.5M | — | Filing → |
| WVE | BUY | 2015-11-18 | $2.0M | — | Filing → |